Johnson & Johnson, MedTech and Varipulse

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports
Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ablation (PFA) system
Johnson & Johnson pauses US rollout of Varipulse heart device after stroke reports
Johnson & Johnson said on Wednesday it temporarily paused the rollout of its Varipulse heart device in the United States as the company investigates four reported stroke events.
Johnson & Johnson MedTech pauses Varipulse rollout in US
Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.
J&J pauses Varipulse pulsed field ablation system's US debut following 4 reports of strokes
“On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. Varipulse cases while we investigate the root cause of four reported neurovascular events in the U.S. External Evaluation,” the company said in its notice.
Varipulse Heart Device Procedures Paused After Safety Events
Just months after FDA approval, Johnson & Johnson paused the rollout of its Varipulse pulsed field ablation (PFA) platform in the U.S. due to safety reasons. In a U.S. external evaluation cohort, four reported neurovascular events occurred among over 130 cases across 14 sites and 40 operators.
J&J pauses Varipulse cases on stroke concerns
Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external evaluation.
J&J Stock Falls After Company Pauses Use of Heart Device
Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, while its rivals gained. J&J said it temporarily paused the use of the heart device,
J&J pauses US rollout of Varipulse heart device after stroke reports
Johnson & Johnson said on Wednesday it has temporarily paused the rollout of its Varipulse heart device in the United States, citing an abundance of caution as the company investigates four reported stroke events.
Medscape2h
J&J Halts Varipulse Field Ablation for AFib
The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.
Hosted on MSN18h
J&J Pauses Sales of Atrial Fibrillation Device, Stock Down
Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...
Johnson & Johnson announces pause of all U.S. Varipulse cases
Johnson & Johnson announced that on January 5, “out of an abundance of caution,” Johnson & Johnson MedTech temporarily paused the U.S.
TCTMD1d
J&J Halts Varipulse Pulsed-Field Ablation Cases in the US
The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.